Dr.Chanchai Sittipunt, Dr.Nakorn Premsri, Dr.Suthipong Watcharasin and Dr.Kiat Ruxrungtham greetings to three Prince Mahidol Award 2021 laureates
Amid a global shortage of vaccines and a new wave of COVID-19 infections, some countries in Southeast Asia are rushing to develop their own coronavirus shots.
COVID19 Vaccine Tracker – Chulalongkorn University: ChulaCov19
The research team behind the development of a local mRNA Covid-19 vaccine on Monday asked the government to help finance the project
The mRNA vaccine, currently being developed by the Vaccine Research Centre of the Faculty of Medicine of Chulalongkorn University, can stimulate the immune system to produce killer T-cells
The Phase 1 trial of Thailand’s homegrown mRNA COVID-19 vaccine ChulaCOV-19, suggests the candidate vaccine can help the body elicit
The Faculty of Medicine at Bangkok’s Chulalongkorn University has put out a call for healthy volunteers to take part in trials of its Covid-19 mRNA vaccine.
TriLink enables Chula VRC to take its Covid-19 vaccine into a First in Human (FIH) phase 1 clinical trial in Thailand with mRNA
With Covid-19 battering Thailand and the third wave bringing the Sinovac-resistant Delta variant to the forefront of the pandemic,
This episode talks about the procedures of vaccine invention and manufacturing and about the new technology of mRNA
Prof Kiat Ruxrungtham from the Center of Excellence in Vaccine Research Center and Development. Photo courtesy of Chulalongkorn Hospital
Kiat Ruxrungtham isn’t content to see Thailand wait in line to buy vaccines from another country.
The first phase of clinical trial on volunteers who have passed the screening process and deemed to be in good health
Thailand is tightening border controls as the country faces its worst coronavirus outbreak.
Chulalongkorn University’s mRNA Covid-19 vaccine, ChulaCov19, began its first round of human trials
Thailand has begun human trials with two of four homegrown vaccine
